IHS Chemical Week

Chemical Week Magazine :: Newsbriefs

Genomatica Raises $41.5 Million, Withdraws IPO

8:32 AM MDT | August 3, 2012

Biobased technology company Genomatica (San Diego) says it has raised $41.5 million in a Series D financing round, which includes new investor and partner Versalis, and that it will withdraw its registration for a public offering. The funding will enable Genomatica to accelerate commercialization of its 1,4-butanediol (BDO) platform and expand its pipeline into other biochemicals, including butadiene, CEO and founder Christophe Schilling tells CW. Schilling says that the company determined private financing was the best option for Genomatica and its shareholders...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa